Valbiotis Shares Surge 48% in Three Months, Facing a Key Technical Threshold
This Thursday morning, Valbiotis shows an increase of 3.35%, bringing its price to 1.05 euros. The biotech company from Clermont has been on a seven-week upward streak, accumulating a nearly 48% gain over the last three months. The stock price is now approaching a major technical threshold that could determine the future movement.
Current Trading Status of Valbiotis
Valbiotis shares are trading at 1.05 euros this morning of March 5th, up from 1.02 euros at the previous day's close. This 3.35% increase continues a trend that began in early December 2025: over three months, the stock has gained 47.89%, having been below 0.71 euros at the end of November. Over the last seven sessions, the increase reaches 8.25%. However, on a rolling year basis, the balance remains negative by nearly 4%, reminding of the significant correction in the first half of 2025. The stock is now exactly at its 20-day moving average (1.05 euros), while remaining well above its 50-day (0.88 euros) and 200-day (0.83 euros) averages, which indicates the strength of the recent rebound. The negative beta of -2.52 shows a pronounced decorrelation with benchmark indices, a common characteristic of small biotech sector capitalizations. The monthly volatility, measured at 13.31, reflects significant price ranges relative to the low absolute valuation of the stock.
Technical Indicators and Market Resistance
Despite the strong quarterly progression, the Relative Strength Index (RSI) remains at 39, a level that does not indicate an overbought situation. This indicator, which measures the speed and magnitude of recent price changes on a scale from 0 to 100, remains below the neutrality threshold of 50, suggesting that the bullish movement has not yet generated short-term technical excesses. The next identifiable hurdle is at 1.21 euros, a resistance level corresponding to the upper boundary of the Bollinger Bands (1.17 euros) and a previous consolidation plateau. A sustained crossing of this zone would constitute an additional technical signal. Conversely, the major support remains positioned at 0.70 euros, the floor reached during last autumn's pullback, a level now 33% away from the current price. The MACD, whose histogram shows a slightly negative value (-0.02), indicates that the medium-term bullish momentum is pausing, even though the signal line remains in positive territory. All these elements outline an intermediate technical context, where the stock has regained ground without yet confirming a long-term trend reversal.
